TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
HALO

Halozyme Therapeutics Inc

Healthcare · Biotechnology

110.40$ +0.5% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Halozyme Therapeutics Inc (HALO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,577 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HALO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
282 262 227 345 357 520 495 475 445 440 429 418 370 566 492 527 524 580 967 1,026 1,185 1,104 1,162 1,781 1,865 1,842 1,699 1,810 1,893 1,733 1,842 1,969 2,118 2,063 2,197 2,054 2,221 2,525 2,673 2,577
273 257 222 341 353 510 484 462 430 428 409 392 342 543 468 500 499 555 942 1,000 1,017 926 989 542 653 739 615 766 879 746 874 988 1,127 1,085 1,262 1,123 1,329 825 1,003 933
61 67 45 115 164 169 98 55 55 58 61 67 59 120 105 134 66 148 499 447 492 119 118 91 147 234 96 221 274 118 165 188 154 116 176 62 420 134 310 163
221 205 179 298 317 469 434 399 364 355 329 287 238 421 368 385 347 368 764 755 816 741 786 209 266 363 276 348 483 336 463 529 666 596 748 548 702 143 319 231
18 16 12 14 15 22 27 34 28 30 28 32 41 59 30 37 63 98 88 153 112 91 114 189 233 231 195 246 217 234 196 215 286 308 305 316 346 441 458 456
13 15 14 15 9.3 5.1 4.4 8.4 18 23 31 44 36 29 41 48 58 61 58 59 56 54 48 98 103 100 108 132 129 128 169 159 131 142 165 182 186 176 155 137
4.4 4.3 3.7 3.3 3.2 3.5 4.9 4.8 6.8 7.5 15 15 15 11 12 11 10 11 10 10 9.6 8.8 8.5 37 37 76 – 75 75 – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – 199 199 409 416 417 417 417 417 417 417 417 417 417 417 580 582 582
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – 976 949 547 529 511 491 473 455 437 420 402 384 366 349 981 952 922
294 294 285 287 285 312 230 220 205 191 169 158 125 474 434 421 425 429 899 906 904 907 902 1,488 1,768 1,672 1,634 1,659 1,643 1,649 1,664 1,680 1,665 1,700 1,714 1,721 1,717 2,477 2,453 2,434
53 55 62 83 102 131 119 132 139 149 139 135 108 86 42 26 27 421 107 114 113 117 112 200 109 131 92 116 115 112 132 133 109 139 150 134 837 177 363 344
12 17 30 46 61 77 82 87 89 92 87 71 55 20 2.9 – – 397 89 89 89 89 90 99 13 13 34 34 32 32 32 31 – – – – 711 – 209 209
4.6 3.6 3.1 5.7 4.2 7.9 3.6 6.2 3.3 4.1 4.1 12 4.3 6.4 8.3 4.1 0.4 1.9 0.5 4.6 3.3 1.5 1.3 12 18 18 8.7 10 19 12 13 15 12 10 20 19 15 21 14 24
200 199 184 166 145 125 103 79 58 35 19 14 9.3 383 387 390 394 – 785 786 786 787 788 1,147 1,491 1,493 1,494 1,496 1,498 1,499 1,501 1,503 1,504 1,506 1,507 1,509 800 2,143 1,936 1,938
-12 -32 -58 58 72 208 265 255 240 249 260 260 245 92 58 106 99 151 68 120 282 197 260 293 97 170 66 151 249 84 178 289 453 364 482 333 504 49 220 144
-558 -585 -618 -649 -646 -522 -479 -501 -529 -531 -530 -544 -569 -604 -610 -584 -548 -475 -434 -342 -126 -59 1.2 24 86 143 66 140 222 91 167 261 398 360 478 361 502 55 205 151
128 128 129 134 143 146 143 144 144 144 147 145 146 141 137 138 142 145 149 148 147 144 141 142 139 139 138 134 134 131 129 129 130 129 127 124 122 118 123 121

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?